8-K Announcements
6Apr 22, 2026·SEC
Feb 27, 2026·SEC
Feb 4, 2026·SEC
Globe Life Inc. (GL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Globe Life Inc. (GL) stock price & volume — 10-year historical chart
Globe Life Inc. (GL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Globe Life Inc. (GL) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 22, 2026 | $3.43vs $3.46-0.9% | $1.6Bvs $1.6B-0.3% |
| Q1 2026 | Feb 4, 2026 | $3.39vs $3.44-1.5% | $1.5Bvs $1.5B-0.8% |
| Q4 2025 | Oct 22, 2025 | $4.81vs $4.60+4.6% | $1.5Bvs $1.5B-0.4% |
| Q3 2025 | Jul 23, 2025 | $3.27vs $3.25+0.6% | $1.5Bvs $1.5B-1.6% |
Globe Life Inc. (GL) competitors in Individual life and final expense insurers — business model, growth, and fundamentals comparison
Globe Life Inc. (GL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Globe Life Inc. (GL) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.16B | 4.31B | 4.53B | 4.74B | 5.12B | 5.23B | 5.45B | 5.78B | 6B |
| Revenue Growth % | 5.63% | 3.82% | 4.93% | 4.66% | 8.08% | 2.06% | 4.22% | 6.07% | 3.82% |
| Medical Costs & Claims | 257.25M | 3.07B | 3.21B | 3.45B | 3.43B | 3.69B | 3.81B | 3.91B | 3.99B |
| Medical Cost Ratio % | 6.19% | 71.2% | 70.85% | 72.9% | 67.06% | 70.51% | 69.89% | 67.63% | 66.6% |
| Gross Profit | 3.9B▲ 0% | 1.24B▼ 68.1% | 1.32B▲ 6.2% | 1.28B▼ 2.7% | 1.69B▲ 31.4% | 1.54B▼ 8.6% | 1.64B▲ 6.4% | 1.87B▲ 14.0% | 2B▲ 7.1% |
| Gross Margin % | 93.81% | 28.8% | 29.15% | 27.1% | 32.94% | 29.49% | 30.11% | 32.37% | 33.4% |
| Gross Profit Growth % | 258.64% | -68.12% | 6.19% | -2.71% | 31.38% | -8.65% | 6.43% | 14.02% | 7.14% |
| Operating Expenses | 3.24B | 379.16M | 388.49M | 387.34M | 412.39M | 439.04M | 445.98M | 543.62M | 540.97M |
| OpEx / Revenue % | 77.96% | 8.79% | 8.58% | 8.17% | 8.05% | 8.4% | 8.19% | 9.41% | 9.02% |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | 84.15% | 79.98% | 79.43% | 81.08% | 75.11% | 78.91% | 78.08% | 77.04% | 75.62% |
| Operating Income | 923.93M▲ 0% | 863.67M▼ 6.5% | 931.28M▲ 7.8% | 896.68M▼ 3.7% | 1.27B▲ 42.1% | 1.1B▼ 13.5% | 1.19B▲ 8.4% | 1.33B▲ 11.1% | 1.46B▲ 10.3% |
| Operating Margin % | 22.23% | 20.02% | 20.57% | 18.92% | 24.89% | 21.09% | 21.92% | 22.96% | 24.38% |
| Operating Income Growth % | 19.64% | -6.52% | 7.83% | -3.71% | 42.15% | -13.53% | 8.36% | 11.08% | 10.26% |
| EBITDA | 915.18M | 953.75M | 1.02B | 983.39M | 1.36B | 1.19B | 1.3B | 1.45B | 1.59B |
| EBITDA Margin % | 22.02% | 22.1% | 22.43% | 20.75% | 26.52% | 22.82% | 23.8% | 25.16% | 26.54% |
| Interest Expense | 85M | 90.08M | 84.31M | 86.7M | 83.49M | 90.39M | 102.32M | 127.09M | 141.22M |
| Non-Operating Income | 8.75M | -90.08M | -84.31M | -86.7M | -83.49M | -90.39M | -102.32M | -127.09M | -129.02M |
| Pretax Income | 830.65M▲ 0% | 863.67M▲ 4.0% | 931.28M▲ 7.8% | 896.68M▼ 3.7% | 1.27B▲ 42.1% | 1.1B▼ 13.5% | 1.19B▲ 8.4% | 1.33B▲ 11.1% | 1.44B▲ 8.5% |
| Pretax Margin % | 19.99% | 20.02% | 20.57% | 18.92% | 24.89% | 21.09% | 21.92% | 22.96% | 24% |
| Income Tax | -627.62M | 162.16M | 170.4M | 164.91M | 243.5M | 207.72M | 223.51M | 255.88M | 278.57M |
| Effective Tax Rate % | -75.56% | 18.78% | 18.3% | 18.39% | 19.1% | 18.85% | 18.72% | 19.29% | 19.35% |
| Net Income | 1.45B▲ 0% | 701.47M▼ 51.8% | 760.79M▲ 8.5% | 731.77M▼ 3.8% | 1.03B▲ 40.9% | 894.39M▼ 13.3% | 970.75M▲ 8.5% | 1.07B▲ 10.3% | 1.16B▲ 8.4% |
| Net Margin % | 34.99% | 16.26% | 16.8% | 15.44% | 20.13% | 17.11% | 17.82% | 18.53% | 19.36% |
| Net Income Growth % | 164.47% | -51.76% | 8.46% | -3.81% | 40.91% | -13.26% | 8.54% | 10.3% | 8.44% |
| EPS (Diluted) | 12.22▲ 0% | 6.08▼ 50.2% | 6.83▲ 12.3% | 6.82▼ 0.1% | 7.22▲ 5.9% | 9.04▲ 25.2% | 10.07▲ 11.4% | 11.94▲ 18.6% | 14.06▲ 17.8% |
| EPS Growth % | 172.16% | -50.25% | 12.34% | -0.15% | 5.87% | 25.21% | 11.39% | 18.57% | 17.76% |
| EPS (Basic) | 12.50 | 6.22 | 6.97 | 6.90 | 7.30 | 9.13 | 10.21 | 11.99 | 14.30 |
| Diluted Shares Outstanding | 118.98M | 115.25M | 111.38M | 107.22M | 103.17M | 98.98M | 96.36M | 84.75M | 80.85M |
Globe Life Inc. (GL) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 23.47B | 23.1B | 25.98B | 29.05B | 29.77B | 25.99B | 28.05B | 29.08B | 30.81B |
| Asset Growth % | 9.51% | -1.62% | 12.48% | 11.82% | 2.48% | -12.7% | 7.95% | 3.65% | 5.98% |
| Total Investment Assets | 17.73B | 17.12B | 19.85B | 22.45B | 22.76B | 18.21B | 19.72B | 19.57B | 20.47B |
| Long-Term Investments | 17.1B | 16.36B | 18.95B | 21.32B | 1.38B | 1.59B | 1.77B | 2.33B | 2.57B |
| Short-Term Investments | 17.1B | 16.36B | 18.95B | 21.32B | 21.37B | 16.62B | 17.95B | 17.24B | 17.9B |
| Total Current Assets | 0 | 0 | 0 | 0 | 22.21B | 17.56B | 18.96B | 18.37B | 19.09B |
| Cash & Equivalents | 118.56M | 121.03M | 75.93M | 94.85M | 92.16M | 92.56M | 103.16M | 165.32M | 144.7M |
| Receivables | 391.77M | 415.16M | 441.66M | 474.18M | 738.75M | 848.75M | 900.62M | 961.7M | 1.04B |
| Other Current Assets | -17.61B | -16.9B | -19.46B | -21.89B | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 441.59M | 441.59M | 441.59M | 441.59M | 5.4B | 6.02B | 6.49B | 6.99B | 7.49B |
| Goodwill | 441.59M | 441.59M | 441.59M | 441.59M | 481.79M | 481.79M | 481.79M | 490.45M | 490.45M |
| Intangible Assets | 0 | 0 | 0 | 0 | 4.91B | 5.54B | 6.01B | 6.5B | 7B |
| PP&E (Net) | 108M | 135M | 161M | 186M | 205M | 212M | 240M | 285M | 370M |
| Other Assets | -17.65B | -16.94B | -19.55B | -21.95B | 577.63M | 607.63M | 592.41M | 1.11B | 1.3B |
| Total Liabilities | 17.24B | 17.68B | 18.68B | 20.28B | 21.13B | 22.04B | 23.56B | 23.77B | 24.84B |
| Total Debt | 1.46B | 1.67B | 1.65B | 1.92B | 2.03B | 2.08B | 2.12B | 2.74B | 2.63B |
| Net Debt | 1.34B | 1.54B | 1.57B | 1.83B | 1.93B | 1.98B | 2.01B | 2.57B | 2.48B |
| Long-Term Debt | 1.13B | 1.36B | 1.35B | 1.67B | 1.55B | 1.63B | 1.63B | 2.32B | 2.32B |
| Short-Term Debt | 328.07M | 307.85M | 298.74M | 254.92M | 479.64M | 449.1M | 486.11M | 415.4M | 304.66M |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 2.72B | 1.65B | 1.75B | 1.94B | 1.98B |
| Accounts Payable | 0 | 0 | 365.4M | 399.51M | 412.94M | 509.36M | 514.88M | 532.83M | 540.83M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 65.47M | 253.36M | 254.57M | 257.63M | 270.66M |
| Other Current Liabilities | -1.97B | -1.71B | -2.14B | -2.49B | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | -1.13B | -1.36B | -1.35B | -1.67B | 16.86B | 18.76B | 20.18B | 19.51B | 20.54B |
| Total Equity | 6.23B▲ 0% | 5.42B▼ 13.1% | 7.29B▲ 34.7% | 8.77B▲ 20.2% | 8.64B▼ 1.5% | 3.95B▼ 54.3% | 4.49B▲ 13.6% | 5.31B▲ 18.2% | 5.97B▲ 12.6% |
| Equity Growth % | 36.45% | -13.1% | 34.7% | 20.25% | -1.46% | -54.3% | 13.6% | 18.25% | 12.61% |
| Shareholders Equity | 6.23B | 5.42B | 7.29B | 8.77B | 8.64B | 3.95B | 4.49B | 5.31B | 5.97B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 4.81B | 5.21B | 5.55B | 5.87B | 6.18B | 6.89B | 7.48B | 8B | 8.55B |
| Common Stock | 124.22M | 121.22M | 117.22M | 113.22M | 109.22M | 105.22M | 102.22M | 97.22M | 92.22M |
| Accumulated OCI | 1.42B | 319.48M | 1.84B | 3.03B | 2.68B | -2.79B | -2.77B | -2.03B | -1.77B |
| Return on Equity (ROE) | 26.93% | 12.05% | 11.97% | 9.11% | 11.84% | 14.21% | 23.01% | 21.87% | 20.59% |
| Return on Assets (ROA) | 6.48% | 3.01% | 3.1% | 2.66% | 3.51% | 3.21% | 3.59% | 3.75% | 3.88% |
| Equity / Assets | 26.54% | 23.45% | 28.08% | 30.2% | 29.03% | 15.2% | 15.99% | 18.25% | 19.39% |
| Debt / Equity | 0.23x | 0.31x | 0.23x | 0.22x | 0.23x | 0.53x | 0.47x | 0.52x | 0.44x |
| Book Value per Share | 52.37 | 46.99 | 65.49 | 81.80 | 83.77 | 39.90 | 46.56 | 62.60 | 73.90 |
| Tangible BV per Share | 48.66 | 43.16 | 61.52 | 77.68 | 31.47 | -20.89 | -20.80 | -19.83 | -18.74 |
Globe Life Inc. (GL) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.43B | 1.28B | 1.36B | 1.48B | 1.44B | 1.42B | 1.48B | 1.4B | 1.4B |
| Operating CF Growth % | 2.17% | -10.6% | 6.75% | 8.25% | -2.62% | -1.08% | 4.24% | -5.4% | -0.43% |
| Operating CF / Revenue % | 34.39% | 29.61% | 30.12% | 31.16% | 28.07% | 27.21% | 27.21% | 24.27% | 23.28% |
| Net Income | 1.46B | 701.51M | 760.88M | 731.77M | 744.96M | 894.39M | 970.75M | 1.07B | 1.16B |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -816.33M | -110.46M | -136.67M | -154.69M | -289.81M | -311.74M | -303.35M | -401.43M | -367.49M |
| Working Capital Changes | 787.12M | 686.59M | 739.66M | 899.35M | 982.53M | 839.54M | 815.01M | 733.1M | 602.64M |
| Cash from Investing | -926.82M | -896.22M | -809.31M | -1.18B | -913.37M | -943.01M | -926.15M | -641.52M | -643.62M |
| Capital Expenditures | -20.29M | -45.09M | -42.2M | -41.76M | -38.24M | -27.93M | -49.55M | -71.05M | -142.48M |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -1.47B | -1.29B | -1.73B | -1.64B | -1.32B | -1.85B | -1.96B | -2.09B | -1.63B |
| Sale/Maturity of Investments | 559.62M | 439.99M | 958.47M | 511.99M | 502.63M | 935.54M | 1.08B | 1.52B | 1.13B |
| Other Investing | 18K | 1.99M | 32K | -7.05M | -56.7M | 0 | 0 | 96K | 0 |
| Cash from Financing | -453.98M | -391.52M | -590.51M | -274.06M | -523.6M | -492.45M | -541.49M | -715.84M | -768.05M |
| Dividends Paid | -68.83M | -71.42M | -74.19M | -78.19M | -80.04M | -80.55M | -84.12M | -85.48M | -86.07M |
| Share Repurchases | -412.99M | -421.75M | -459.57M | -443.87M | -541.43M | -454.64M | -511.1M | -1B | -880.98M |
| Stock Issued | 61.22M | 36.09M | 83.16M | 48.09M | 69.83M | 106.59M | 114.08M | 51.79M | 164.45M |
| Debt Issuance (Net) | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K |
| Other Financing | -90.93M | -126.99M | -121.43M | -72.93M | -64.24M | -112.79M | -96.94M | -301.61M | 145.29M |
| Net Change in Cash | 42.4M▲ 0% | 2.46M▼ 94.2% | -45.09M▼ 1930.8% | 18.91M▲ 141.9% | -2.68M▼ 114.2% | 396K▲ 114.8% | 10.6M▲ 2576.0% | 62.17M▲ 486.7% | -20.62M▼ 133.2% |
| Exchange Rate Effect | -5.85M | 12.56M | -9.15M | -1.73M | -3.39M | 13.67M | -4.19M | 17.08M | -5.34M |
| Cash at Beginning | 76.16M | 118.56M | 121.03M | 75.93M | 94.85M | 92.16M | 92.56M | 103.16M | 165.32M |
| Cash at End | 118.56M | 121.03M | 75.93M | 94.85M | 92.16M | 92.56M | 103.16M | 165.32M | 144.7M |
| Free Cash Flow | 1.41B▲ 0% | 1.23B▼ 12.5% | 1.32B▲ 7.2% | 1.43B▲ 8.6% | 1.4B▼ 2.5% | 1.39B▼ 0.4% | 1.43B▲ 2.8% | 1.33B▼ 7.1% | 1.25B▼ 5.8% |
| FCF Growth % | 2.56% | -12.51% | 7.23% | 8.55% | -2.46% | -0.37% | 2.77% | -7.08% | -5.82% |
| FCF Margin % | 33.9% | 28.57% | 29.19% | 30.28% | 27.33% | 26.68% | 26.3% | 23.04% | 20.9% |
| FCF per Share | 11.84 | 10.69 | 11.87 | 13.38 | 13.56 | 14.09 | 14.87 | 15.71 | 15.51 |
Globe Life Inc. (GL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 80.37% | 84.15% | 79.98% | 79.43% | 81.08% | 75.11% | 78.91% | 78.08% | 77.04% | 75.62% |
| Medical Cost Ratio | 72.37% | 6.19% | 71.2% | 70.85% | 72.9% | 67.06% | 70.51% | 69.89% | 67.63% | 66.6% |
| Return on Equity (ROE) | 12.75% | 26.93% | 12.05% | 11.97% | 9.11% | 11.84% | 14.21% | 23.01% | 21.87% | 20.59% |
| Return on Assets (ROA) | 2.66% | 6.48% | 3.01% | 3.1% | 2.66% | 3.51% | 3.21% | 3.59% | 3.75% | 3.88% |
| Equity / Assets | 21.3% | 26.54% | 23.45% | 28.08% | 30.2% | 29.03% | 15.2% | 15.99% | 18.25% | 19.39% |
| Book Value / Share | 37.32 | 52.37 | 46.99 | 65.49 | 81.8 | 83.77 | 39.9 | 46.56 | 62.6 | 73.9 |
| Debt / Equity | 0.31x | 0.23x | 0.31x | 0.23x | 0.22x | 0.23x | 0.53x | 0.47x | 0.52x | 0.44x |
| Revenue Growth | 4.48% | 5.63% | 3.82% | 4.93% | 4.66% | 8.08% | 2.06% | 4.22% | 6.07% | 3.82% |
Globe Life Inc. (GL) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 22, 2026·SEC
Feb 27, 2026·SEC
Feb 4, 2026·SEC
Globe Life Inc. (GL) stock FAQ — growth, dividends, profitability & financials explained
Globe Life Inc. (GL) grew revenue by 3.8% over the past year. Growth has been modest.
Yes, Globe Life Inc. (GL) is profitable, generating $1.16B in net income for fiscal year 2025 (19.4% net margin).
Yes, Globe Life Inc. (GL) pays a dividend with a yield of 0.69%. This makes it attractive for income-focused investors.
Globe Life Inc. (GL) has a return on equity (ROE) of 20.6%. This is excellent, indicating efficient use of shareholder capital.
Globe Life Inc. (GL) has a combined ratio of 75.6%. A ratio below 100% indicates underwriting profitability.
Globe Life Inc. (GL) financial analysis — history, returns, DCA and operating performance tools
Analyst verdict, bull/bear case, risk factors and peer comparison
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates